 |
|
|
| |
Perceptions of Cabotegravir + Rilpivirine Long-Acting
(CAB + RPV LA) From People Living With HIV (PLHIV) in the CARLOS Study
|
| |
| |
IAS 2023 july 24
Jenny Scherzer1, Sebastian Noe2, Celia Jonsson-Oldenbüttel2, Christoph Wyen3, Stefan Esser4, Gordon Weinberg5, Anja Potthoff6,7, Ivanka Krznaric8, Bernd Westermayer9, Katharina Bernhardt1, Patricia de los Rios10
1ViiV Healthcare, Munich, Germany; 2MVZ München am Goetheplatz, Munich, Germany; 3Praxis am Ebertplatz, Cologne, Germany; 4University Hospital Duisburg-Essen, Essen, Germany; 5Infektiologisches Zentrum Steglitz, Berlin, Germany; 6WIR-Walk In Ruhr, Center for Sexual Health and Medicine, Bochum, Germany; 7Ruhr-Universität Bochum, Bochum, Germany;
8Praxis an der Kulturbrauerei, Berlin, Germany
|
| |
|
|
|
|
|
